Effects of induction with novel agents versus conventional chemotherapy on mobilization and autologous stem cell transplant outcomes in multiple myeloma.
about
A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myelomaSerum free light chains in myeloma patients with an intact M protein by immunofixation: potential roles for response assessment and prognosis during induction therapy with novel agentsPositive ALDH1A3 and negative GPX3 expressions are biomarkers for poor prognosis of gallbladder cancerLong-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myeloma.Current strategies for the management of autologous peripheral blood stem cell mobilization failures in patients with multiple myeloma.Musashi-1 Expression is a Prognostic Factor in Ovarian Adenocarcinoma and Correlates with ALDH-1 Expression.
P2860
Effects of induction with novel agents versus conventional chemotherapy on mobilization and autologous stem cell transplant outcomes in multiple myeloma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Effects of induction with nove ...... outcomes in multiple myeloma.
@ast
Effects of induction with nove ...... outcomes in multiple myeloma.
@en
type
label
Effects of induction with nove ...... outcomes in multiple myeloma.
@ast
Effects of induction with nove ...... outcomes in multiple myeloma.
@en
prefLabel
Effects of induction with nove ...... outcomes in multiple myeloma.
@ast
Effects of induction with nove ...... outcomes in multiple myeloma.
@en
P2093
P2860
P1433
P1476
Effects of induction with nove ...... outcomes in multiple myeloma.
@en
P2093
Courtney E Bakan
David Krugh
Don M Benson
Kathryn Panzner
Lynn O'Donnell
Megan K Smith
Steven M Devine
P2860
P304
P356
10.3109/10428190903480728
P577
2010-02-01T00:00:00Z